Please login to the form below
pitavastatin
This page shows the latest pitavastatin news and features for those working in and with pharma, biotech and healthcare.
Recordati snaps up Swiss pharma company Pro Farma
The Italian firm has already launched its own oral treatment for disorders of lipoprotein metabolism, Livazo (pitavastatin), on the Swiss market, having been approved for use in adults by the European
Latest news
-
Label change for Lilly's Livalo
The US Food and Drug Administration (FDA) has said Eli Lilly &Company can update the label of cholesterol drug Livalo (pitavastatin) to remove a warning against the use of the drug
-
Thin on the ground
Pitavastatin. Livalo (Kowa Pharmaceuticals America, Eli Lilly). Primary hyperlipidaemia or mixed dyslipidaemia.
-
Pharma news in brief
The Swiss firm said it decided to stop the development of NKS104 (pitavastatin), a lipid lowering statin, as ìdata from recent investigational trials showed the compound was no longer competitive enoughî.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Country report: The healthcare market in Germany
Out of the 10 products assessed last year, four have obtained poor innovation scores: Esbriet (pirfenidone), Livazo (pitavastatin), Yellox (bromfenac) and Trajenta (linagliptin) and a majority of manufacturers have struggled – sometimes
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Medscape Education Global
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
